125 results
8-K
EX-99.1
NTRA
Natera, Inc.
8 Aug 24
Natera Reports Second Quarter 2024 Financial Results
4:11pm
, dispositions or other strategic transactions that may not achieve our anticipated benefits and could otherwise disrupt our business, cause dilution
8-K
EX-99.2
NTRA
Natera, Inc.
8 Aug 24
Natera Reports Second Quarter 2024 Financial Results
4:11pm
benefits and could otherwise disrupt our business, cause dilution to our stockholders or reduce our financial resources ; we may not be successful … . Recognizes the clinical utility and benefits of genetics in CKD. With NKF and KDIGO, two of the major nephrology organizations now recommend genetic
8-K
EX-99.1
slytqp497uwc1ed0do1x
9 May 24
Natera Reports First Quarter 2024 Financial Results
4:13pm
8-K
EX-99.2
7jje6i5 vn3zore
9 May 24
Natera Reports First Quarter 2024 Financial Results
4:13pm
8-K
EX-99.1
2sie kztx0
28 Feb 24
Natera Reports Fourth Quarter and Full Year 2023 Financial Results
4:11pm
8-K
EX-99.2
6zr tdmd1o55extkr038
28 Feb 24
Natera Reports Fourth Quarter and Full Year 2023 Financial Results
4:11pm
8-K
EX-99.1
kqalnh
22 Jan 24
Natera Acquires Reproductive Health Assets from Invitae
7:05am
8-K
EX-99.2
j4meamgws8ufabzqwha
9 Jan 24
Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
7:07am
8-K
EX-99.2
2aus4obrhf f6
8 Nov 23
Natera Reports Third Quarter 2023 Financial Results
4:12pm
8-K
EX-99.1
xfyh60o60oshfkb9 gt
8 Nov 23
Natera Reports Third Quarter 2023 Financial Results
4:12pm
8-K
EX-1.1
kxc mkg1ba
7 Sep 23
Natera Launches Proposed Follow-On Offering
5:08pm